Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 13.59% is 39% below its 3-year average of 22.39%, near the low end of its 3-year range (10.64%–136.51%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.39% below its 12-month average of 18.98%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.59%.
DEBT TO ASSETS RATIO
13.59%
DEBT TO ASSETS RATIO AVG TTM
18.98%
DEBT TO ASSETS RATIO AVG 3Y
40.52%
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-28.39%
CURRENT VS 3Y AVG
-66.45%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 584 covered companies
CURRENT VS SECTOR MEDIAN
+13492.92%
vs the sector median at left
eXoZymes, Inc.
Market Cap
$55.97M
Debt to Assets Ratio
13.59%
TTM Avg
18.98%
3Y Avg
40.52%
5Y Avg
N/A
Market Cap
$56.37M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$56.52M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$54.14M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.55M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$59.10M
Debt to Assets Ratio
0.74%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| eXoZymes, Inc. (EXOZ) | $55.97M | 13.59% | 18.98% | 40.52% | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.37M | 0.01% | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $56.52M | 0.00% | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $55.01M | 0.84% | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $54.14M | 0.00% | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $57.91M | 0.00% | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.55M | 0.00% | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | 0.01% | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $59.10M | 0.74% | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $59.36M | 0.09% | N/A | N/A | N/A |
Debt/Assets
13.6%
Debt/Equity
0.30
Current Ratio
3.81
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 13.59% |
| 2026-03-31 | 28.99% |
| 2025-12-31 | 20.82% |
| 2025-09-30 | 17.10% |
| 2025-06-30 | 14.41% |
| 2025-03-31 | 11.51% |
| 2024-12-31 | 10.64% |
| 2024-09-30 | 136.51% |
| 2024-06-30 | 107.91% |
| 2024-03-31 | 38.90% |
| 2023-12-31 | 45.29% |
| 2022-12-31 | 22.67% |
